[1] Bossone E,Eagle KA. Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes[J]. Nat Rev Cardiol,2021, 18: 331-348. [2] 中华医学会外科学分会血管外科学组. 腹主动脉瘤诊断和治疗中国专家共识(2022版)[J]. 中国实用外科杂志,2022, 42: 380-387. [3] Gao J, Cao H, Hu G, et al. The mechanism and therapy of aortic aneurysms[J]. Signal Transduct Target Ther,2023, 8: 55. doi: 10.1038/s41392-023-01325-7. [4] Lu H, Sun J, Liang W, et al. Cyclodextrin prevents abdominal aortic aneurysm via activation of vascular smooth muscle cell transcription factor EB[J]. Circulation,2020, 142: 483-498. [5] Abu-Farha M, Ghosh A, Al-Khairi I, et al. The multi-faces of angptl8 in health and disease: novel functions beyond lipoprotein lipase modulation[J]. Prog Lipid Res, 2020, 80: 101067. doi: 10.1016/j.plipres.2020.101067. [6] Jiao X, Yang Y, Li L, et al. Angiopoietin-like protein 8 accelerates atherosclerosis in apoE mice[J]. Atherosclerosis,2020, 307: 63-71. [7] Jiao X, He J, Yang Y, et al. Associations between circulating full-length angiopoietin-like protein 8 levels and severity of coronary artery disease in Chinese non-diabetic patients: a case-control study[J]. Cardiovasc Diabetol,2018, 17: 92. doi: 10.1186/s12933-018-0736-6. [8] Yang Y, Jiao X, Li L, et al. Increased circulating angiopoietin-like protein 8 levels are associated with thoracic aortic dissection and higher inflammatory conditions. Cardiovasc Drugs Ther, 2020, 34: 65-77. [9] Hu L, Wei J, Zhang Y, et al. ANGPTL8 is a negative regulator in pathological cardiac hypertrophy[J]. Cell Death Dis,2022, 13: 621. doi: 10.1038/s41419-022-05029-8. [10] Yang YY, Jiao XL, Yu HH, et al. Angiopoietin-like protein 8 deficiency attenuates thoracic aortic aneurysm/dissection development in beta-aminopropionitrile monofumarate-induced model mice[J]. Biochim Biophys Acta Mol Basis Dis,2023, 1869: 166619. doi: 10.1016/j.bbadis.2022.166619. [11] Yu H, Jiao X, Yang Y, et al. ANGPTL8 deletion attenuates abdominal aortic aneurysm formation in apoE-/- mice[J]. Clin Sci (Lond), 2023, 137:979-993. [12] Sachdeva J, Mahajan A, Cheng J, et al. Smooth muscle cell-specific Notch1 haploinsufficiency restricts the progression of abdominal aortic aneurysm by modulating CTGF expression[J]. PloS One,2017, 12: e0178538. doi: 10.1371/journal.pone.0178538. [13] Cao X, Cai Z, Liu J, et al. miRNA-504 inhibits p53-dependent vascular smooth muscle cell apoptosis and may prevent aneurysm formation[J]. Mol Med Rep,2017, 16: 2570-2578. [14] Taherkhani F, Hosseini K, Zebardast S, et al. Anti proliferative and apoptotic effects on pancreatic cancer cell lines indicate new roles for ANGPTL8 (Betatrophin)[J]. Genetics and molecular biology,2020, 43: e20190196. doi: 10.1590/1678-4685-gmb-2019-0196. [15] Monzavi N, Zargar S, Gheibi N, et al. Angiopoietin-like protein 8 (betatrophin) may inhibit hepatocellular carcinoma through suppressing of the Wnt signaling pathway[J]. Iran J Basic Med Sci,2019, 22: 1166-1171. [16] Wang J, Thomas HR, Li Z, et al. Puma, noxa, p53, and p63 differentially mediate stress pathway induced apoptosis[J]. Cell Death Dis,2021, 12: 659. doi: 10.1038/s41419-021-03902-6. |